Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts)

Skřickova Jana,Zdeněk Bortlicek,K Hejduk,Milos Pesek,Vitězslav Kolek,Koubkova Leona,Tomiskova Marcela,Jaromir Roubec,Petr Zatloukal,Frantisek Salajka

Lung Cancer（2012）

引用 0|浏览19

暂无评分

摘要

The Czech Republic has had an opportunity to use pemetrexed for 1st line treatment of advanced NSCLC from the year 2008. The purpose of this trial was to evaluate the activity and feasibility of pemetrexed in 1st line treatment NSCLC patients.

查看译文

关键词

pemetrexed,lung cancer,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要